Isotopically labeled triazolopyridine 11-beta hydroxysteroid dehydrogenase type I inhibitors

摘要

Novel compounds are provided which are 11-beta-hydroxysteroid dehydrogenase type I inhibitors. 11-beta-hydroxysteroid dehydrogenase type I inhibitors are useful in treating, preventing, or slowing the progression of diseases requiring 11-beta-hydroxysteroid dehydrogenase type I inhibitor therapy. These novel compounds of formula I: or stereoisomers or pharmaceutically acceptable salts thereof, wherein R* is an isotopically labeled hydroxypropyl moiety.;

主权项

1. A compound, enantiomer, diastereomer, or salt thereof, of a compound of formula I: wherein R* is an isotopically labeled hydroxypropyl moiety.